In our previous two blogs, we briefly looked at the impact of new technologies on how clinical trials are conducted. In part 1 we touched briefly on the effect ‘wearables’ might have on research techniques. Wearables are data collection devices patients wear that transmit research data back to a research facility. In part 2 we looked at the application of ‘Big Data’ to the growing amounts of information being gathered during clinical trials. Big Data is a term applied to analytical techniques used to process large amounts of research data. Both of these advances help provide more and better research test results.

In this blog we’ll look at a third development – ‘The Cloud’ – that is also changing the shape of how clinical trials are being conducted. Essentially, The Cloud is a central storage and processing facility (computer servers) into which data flows from multiple remote sources. This data is stored centrally on these servers and can be accessed by multiple users from virtually any geographic location. Because of this, the data from many research sites can be gathered into one location and analyzed either as a single data set or divided into sub-sets to examine various study components.

The Cloud capabilities provide a great many advantages to researchers today over research methods of only a few years ago.

  1. Data from multiple research sites can be consolidated into a single set of data allowing researchers access to more information than was previously available from which to draw conclusions.
  2. Data from a broader range of study participants from more diverse settings can be grouped for analysis, although these participants may be physically located anywhere in the world.
  3. The pool from which study participants are drawn can be much larger, allowing individuals to participate who might otherwise not be able to join a study.
  4. Clinical trial data showing the effects of new medications and treatments can be collected and analyzed much more quickly than was possible in the past. As a result, the efficacy of new approaches to diseases can be known earlier and with more certainty. The speed with which analysis can now be carried out allows new medications to reach consumers faster than in the past.
  5. Because there is more data from more participants available to researchers, sub-sets of data can be isolated for specific analysis. Thus, unique groups of patients with particular conditions can be analyzed separately from the larger group. For example, researchers may want to examine how a new medication for arthritis acts in patients who also have diabetes. This kind of analysis may not be possible at isolated study sites where there are not enough diabetes patients to yield valid results.

Many of these new tools and techniques are only now being tried within the research community, but results are promising. DM Clinical Research is on the cutting edge of developments across all aspects of clinical trials. We are currently conducting research trials examining new approaches and vaccines for Meningitis, Rheumatoid Arthritis, Clostridium Difficile (C Diff), Type 2 Diabetes, and COPD. If you believe you may be a candidate for one of our clinical trials currently underway, please give us a call at 281-517-0550. If you are selected to participate, you will receive the most advanced treatments available free of charge, along with free doctor evaluations, and lab work. Participants are also compensated for their time and travel.

Give us a call, and one of our professional staff will be glad to assist you and answer any questions you may have: 281-517-0550.